Free Trial

MarketBeat Instant News Alerts

Axsome Therapeutics logo with Healthcare background

Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launch

Axsome Therapeutics (NASDAQ:AXSM) executives said growth in new prescriptions for AUVELITY and an expanded sales team are positioning the company for further growth following the drug’s launch for Alzheimer’s disease agitation. Speaking at the UBS Biopharma Conference in London, Chief Financial Off

NASDAQ:AXSM
Read Axsome Therapeutics Sees AUVELITY Prescription Surge After Alzheimer’s Agitation Launch
H World Group logo with Consumer Discretionary background

What H World Group (HTHT) Said on Its Q3 Earnings Call

H World Group (NASDAQ:HTHT) raised its full-year revenue growth guidance after reporting higher third-quarter revenue and profit, as expansion of its managed and franchised hotel network helped offset a decline in revenue from leased and owned properties. The hotel operator said group revenue rose

NASDAQ:HTHT
Read What H World Group (HTHT) Said on Its Q3 Earnings Call
MasTec logo with Industrials background

MasTec (NYSE:MTZ) Price Target Cut to $335.00 by Analysts at Guggenheim

Guggenheim cut their price target on shares of MasTec from $518.00 to $335.00 and set a "buy" rating on the stock in a report on Monday.

NYSE:MTZ
Read MasTec (NYSE:MTZ) Price Target Cut to $335.00 by Analysts at Guggenheim
ArriVent BioPharma logo with Healthcare background

ArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at Guggenheim

Guggenheim dropped their price target on ArriVent BioPharma from $30.00 to $28.00 and set a "buy" rating for the company in a research report on Monday.

NASDAQ:AVBP
Read ArriVent BioPharma (NASDAQ:AVBP) Stock Price Target Lowered at Guggenheim
Jade Biosciences logo with Healthcare background

Jade Biosciences (NASDAQ:JBIO) Stock Price Target Lowered at Guggenheim

Guggenheim decreased their target price on shares of Jade Biosciences from $47.00 to $41.00 and set a "buy" rating on the stock in a research report on Monday.

NASDAQ:JBIO
Read Jade Biosciences (NASDAQ:JBIO) Stock Price Target Lowered at Guggenheim
Praxis Precision Medicines logo with Healthcare background

Guggenheim Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price

Guggenheim upped their target price on Praxis Precision Medicines from $800.00 to $1,050.00 and gave the company a "buy" rating in a research note on Monday.

NASDAQ:PRAX
Read Guggenheim Issues Positive Forecast for Praxis Precision Medicines (NASDAQ:PRAX) Stock Price

Trending News

All MarketBeat Instant News Alerts

Zevra Therapeutics logo with Healthcare background

Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price

NASDAQ:ZVRA
Read Guggenheim Has Lowered Expectations for Zevra Therapeutics (NASDAQ:ZVRA) Stock Price
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Acquires $15,000.00 in Stock
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Robert Williamson III Buys 18,609 Shares of Stock
Perspective Therapeutics logo with Healthcare background

Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock

NYSEAMERICAN:CATX
Read Perspective Therapeutics (NYSEAMERICAN:CATX) Director Purchases $19,950.00 in Stock
Dynex Capital logo with Finance background

Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock

NYSE:DX
Read Dynex Capital (NYSE:DX) CEO Acquires $25,740.00 in Stock
Csquare logo with background

Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock

NYSE:CSQR
Read Insider Buying: Csquare (NYSE:CSQR) Director Acquires $33,920.00 in Stock
Abeona Therapeutics logo with Healthcare background

Abeona Therapeutics (NASDAQ:ABEO) Director Faith Charles Acquires 15,000 Shares of Company Stock

NASDAQ:ABEO
Read Abeona Therapeutics (NASDAQ:ABEO) Director Faith Charles Acquires 15,000 Shares of Company Stock
Dynex Capital logo with Finance background

Dynex Capital (NYSE:DX) Stock: Insider Byron Boston Acquires 4,965 Shares

NYSE:DX
Read Dynex Capital (NYSE:DX) Stock: Insider Byron Boston Acquires 4,965 Shares
Radcom logo with Technology background

Insider Selling: Radcom (NASDAQ:RDCM) Director Sells $66,000.00 in Stock

NASDAQ:RDCM
Read Insider Selling: Radcom (NASDAQ:RDCM) Director Sells $66,000.00 in Stock
PureCycle Technologies logo with Materials background

PureCycle Technologies (NASDAQ:PCT) Chairman Acquires $98,496.00 in Stock

NASDAQ:PCT
Read PureCycle Technologies (NASDAQ:PCT) Chairman Acquires $98,496.00 in Stock
Amdocs logo with Technology background

Insider Buying: Amdocs (NASDAQ:DOX) Director Purchases $102,239.47 in Stock

NASDAQ:DOX
Read Insider Buying: Amdocs (NASDAQ:DOX) Director Purchases $102,239.47 in Stock
TriSalus Life Sciences logo with Healthcare background

TriSalus Life Sciences (NASDAQ:TLSI) Director Purchases 50,000 Shares of Company Stock

NASDAQ:TLSI
Read TriSalus Life Sciences (NASDAQ:TLSI) Director Purchases 50,000 Shares of Company Stock
Donegal Group logo with Finance background

Insider Buying: Donegal Group (NASDAQ:DGICA) Major Shareholder Acquires 7,500 Shares of Stock

NASDAQ:DGICA
Read Insider Buying: Donegal Group (NASDAQ:DGICA) Major Shareholder Acquires 7,500 Shares of Stock
CorMedix logo with Healthcare background

CorMedix (NASDAQ:CRMD) Stock: Insider Joseph Todisco Buys 80,000 Shares

NASDAQ:CRMD
Read CorMedix (NASDAQ:CRMD) Stock: Insider Joseph Todisco Buys 80,000 Shares
ExlService logo with Industrials background

ExlService (NASDAQ:EXLS) Stock: Insider Rohit Kapoor Sells 100,000 Shares

NASDAQ:EXLS
Read ExlService (NASDAQ:EXLS) Stock: Insider Rohit Kapoor Sells 100,000 Shares
HubSpot logo with Technology background

HubSpot (NYSE:HUBS) Stock: Insider Brian Halligan Acquires 22,985 Shares

NYSE:HUBS
Read HubSpot (NYSE:HUBS) Stock: Insider Brian Halligan Acquires 22,985 Shares
Ceva logo with Technology background

Ceva (NASDAQ:CEVA) Raised to Buy at Cfra

NASDAQ:CEVA
Read Ceva (NASDAQ:CEVA) Raised to Buy at Cfra
SolarEdge Technologies logo with Industrials background

SolarEdge Technologies (NASDAQ:SEDG) Stock Price Target Cut by Wells Fargo & Company

NASDAQ:SEDG
Read SolarEdge Technologies (NASDAQ:SEDG) Stock Price Target Cut by Wells Fargo & Company
Bullish logo with Finance background

Bullish (NYSE:BLSH) Price Target Cut to $28.00 by Analysts at Wells Fargo & Company

NYSE:BLSH
Read Bullish (NYSE:BLSH) Price Target Cut to $28.00 by Analysts at Wells Fargo & Company
CareTrust REIT logo with Real Estate background

CareTrust REIT (NYSE:CTRE) Stock Keeps "Market Outperform" Rating at Citizens Jmp

NYSE:CTRE
Read CareTrust REIT (NYSE:CTRE) Stock Keeps "Market Outperform" Rating at Citizens Jmp
Edwards Lifesciences logo with Healthcare background

Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says

NYSE:EW
Read Edwards Lifesciences (NYSE:EW) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says
Haemonetics logo with Healthcare background

Haemonetics (NYSE:HAE) Price Target Raised to $144.00

NYSE:HAE
Read Haemonetics (NYSE:HAE) Price Target Raised to $144.00
SM Energy logo with Energy background

SM Energy (NYSE:SM) Upgraded at Seaport Research Partners

NYSE:SM
Read SM Energy (NYSE:SM) Upgraded at Seaport Research Partners
United Dominion Realty Trust logo with Real Estate background

United Dominion Realty Trust (NYSE:UDR) Upgraded to "Outperform" at Zelman & Associates

NYSE:UDR
Read United Dominion Realty Trust (NYSE:UDR) Upgraded to "Outperform" at Zelman & Associates

Featured Articles and Offers

Alert Categories

All Alerts